RJFSA
IART icon

Raymond James Financial Services Advisors’s Integra LifeSciences IART Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,219
Closed -$210K – 3502
2024
Q2 		$210K Buy
7,219
+833
+13% +$24.7K ﹤0.01% 3092
2024
Q1 		$226K Buy
+6,386
New +$255K ﹤0.01% 3026
2022
Q1 		– Sell
-215,001
Closed -$14.4M – 3390
2021
Q4 		$14.4M Buy
+215,001
New +$14.5M 0.03% 549

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial Services Advisors's IART Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 7,219 shares — an estimated $210K sold.

Raymond James Financial Services Advisors first reported a position in IART in Q4 2021 and held it in 3 quarters. The position peaked at $14.4M in Q4 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Raymond James Financial Services Advisors reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 7,219 Integra LifeSciences shares in Q3 2024, an estimated $210K.
  • Raymond James Financial Services Advisors first reported a position in Integra LifeSciences in Q4 2021 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's Integra LifeSciences position peaked at $14.4M in Q4 2021.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.